Domenico De Berardis
Domenico De Berardis
NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
Alexithymia and body image in adult outpatients with binge eating disorder
A Carano, D De Berardis, F Gambi, C Di Paolo, D Campanella, L Pelusi, ...
International Journal of Eating Disorders 39 (4), 332-340, 2006
Alexithymia and its relationships with dissociative experiences and Internet addiction in a nonclinical sample
D De Berardis, A D'Albenzio, F Gambi, G Sepede, A Valchera, CM Conti, ...
CyberPsychology & Behavior 12 (1), 67-69, 2009
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study
G Martinotti, G Sepede, F Gambi, G Di Iorio, D De Berardis, M Di Nicola, ...
Journal of clinical psychopharmacology 32 (4), 487-491, 2012
Insight and alexithymia in adult outpatients with obsessive–compulsive disorder
D De Berardis, D Campanella, F Gambi, G Sepede, G Salini, A Carano, ...
European archives of psychiatry and clinical neuroscience 255 (5), 350-358, 2005
Affective and cognitive empathy in adolescents with autism spectrum disorder
M Mazza, MC Pino, M Mariano, D Tempesta, M Ferrara, D De Berardis, ...
Frontiers in human neuroscience 8, 791, 2014
Alexithymia and its relationships with body checking and body image in a non-clinical female sample
D De Berardis, A Carano, F Gambi, D Campanella, P Giannetti, A Ceci, ...
Eating behaviors 8 (3), 296-304, 2007
Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review
G Martinotti, G Di Iorio, S Marini, V Ricci, D De Berardis, ...
Journal of biological regulators and homeostatic agents 26 (3), 347, 2012
The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature
D De Berardis, CMV Conti, N Serroni, FS Moschetta, L Olivieri, A Carano, ...
International Journal of Immunopathology and Pharmacology 23 (2), 417-422, 2010
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine
D De Berardis, G Di Iorio, T Acciavatti, C Conti, N Serroni, L Olivieri, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2011
Role of melatonin in mood disorders and the antidepressant effects of agomelatine
V Srinivasan, D De Berardis, SD Shillcutt, A Brzezinski
Expert opinion on investigational drugs 21 (10), 1503-1522, 2012
An update of safety of clinically used atypical antipsychotics
L Orsolini, C Tomasetti, A Valchera, R Vecchiotti, I Matarazzo, F Vellante, ...
Expert opinion on drug safety 15 (10), 1329-1347, 2016
Major depressive disorder, anhedonia and agomelatine: an open-label study.
M Di Giannantonio, G Di Iorio, R Guglielmo, D De Berardis, CM Conti, ...
Journal of Biological Regulators and Homeostatic Agents 25 (1), 109-114, 2011
Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial
G Sepede, D De Berardis, F Gambi, D Campanella, R La Rovere, ...
Journal of Clinical Psychopharmacology 26 (1), 45-49, 2006
Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study
F Gambi, D De Berardis, D Campanella, A Carano, G Sepede, G Salini, ...
Journal of psychopharmacology 19 (5), 483-487, 2005
Alexithymia and suicide risk in psychiatric disorders: a mini-review
D De Berardis, M Fornaro, L Orsolini, A Valchera, A Carano, F Vellante, ...
Frontiers in psychiatry 8, 148, 2017
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant …
F Iasevoli, S Giordano, R Balletta, G Latte, MV Formato, E Prinzivalli, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 34-48, 2016
Out of touch with reality? Social perception in first-episode schizophrenia
SJH Ebisch, A Salone, F Ferri, D De Berardis, GL Romani, FM Ferro, ...
Social cognitive and affective neuroscience 8 (4), 394-403, 2013
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice
D De Berardis, S Marini, M Fornaro, V Srinivasan, F Iasevoli, C Tomasetti, ...
International journal of molecular sciences 14 (6), 12458-12483, 2013
Suicide during perinatal period: epidemiology, risk factors, and clinical correlates
L Orsolini, A Valchera, R Vecchiotti, C Tomasetti, F Iasevoli, M Fornaro, ...
Frontiers in psychiatry 7, 138, 2016
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis
S Galderisi, P Rucci, B Kirkpatrick, A Mucci, D Gibertoni, P Rocca, A Rossi, ...
JAMA psychiatry 75 (4), 396-404, 2018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20